Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Schroders
AddedMar 20, 2024
UpdatedJun 28, 2026
Schroders

Schroders

Operating

Global asset manager offering diverse investment options to various clients.

Location
London, Greater London, GB
Founded
1804
Firm
Compare
Portfolio
Fundraising
Employees
News
Website

Investments

Redcliffe Lifetech
Redcliffe Lifetech
Series Unknown

Total Raised

$108.1M

Rounds

5

Series B$61MMay 2022
Antler
Antler

Total Raised

$82.2M

Rounds

4

Series Unknown$25MFebruary 2020
Benchmark Capital
Benchmark Capital

Rounds

1

Corporate RoundOctober 2016
Insulet
Insulet
Public

Total Raised

$179.5M

Rounds

7

Series E$50MFebruary 2006
Series B$11MAugust 2001
Quick Study Radiology
Quick Study Radiology

Total Raised

$13.6M

Rounds

8

Series C$1.2MJuly 2005
Series C$902kOctober 2004
Series B$962kJuly 2003
Series A$5.2MJuly 2002
Medifacts International
Medifacts International

Total Raised

$21M

Rounds

2

Series A$16MJanuary 2005
Just Kratom Store
Just Kratom Store

Total Raised

$76M

Rounds

3

Series C$48MAugust 2004
Rejuvenon
Rejuvenon

Total Raised

$49M

Rounds

2

Series B$37MJune 2004
Dynogen Pharmaceuticals
Dynogen Pharmaceuticals
Acquired

Total Raised

$63.3M

Rounds

2

Series B$50MApril 2004
Archemix
Archemix
Public

Total Raised

$101.8M

Rounds

2

Series B$50MApril 2004
Eunoe
Eunoe

Total Raised

$40M

Rounds

1

Series Unknown$40MJune 2003
Maverix.Net
Maverix.Net
Acquired

Total Raised

$42.5M

Rounds

1

Series D$42.5MMarch 2000
CardioFocus
CardioFocus
Public

Total Raised

$268M

Rounds

20

Series B$9.6MJanuary 2000